(19)
(11) EP 4 384 278 A1

(12)

(43) Date of publication:
19.06.2024 Bulletin 2024/25

(21) Application number: 22947055.4

(22) Date of filing: 01.11.2022
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07C 211/42(2006.01)
A61K 31/122(2006.01)
C07C 211/30(2006.01)
C07C 50/12(2006.01)
(52) Cooperative Patent Classification (CPC):
C07C 211/30; C07C 211/42; A61P 35/00; A61K 31/122; C07D 211/00
(86) International application number:
PCT/TR2022/051215
(87) International publication number:
WO 2024/085824 (25.04.2024 Gazette 2024/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 19.10.2022 TR 202215931

(71) Applicants:
  • Istinye Üniversitesi
    34010 Zeytinburnu Istanbul (TR)
  • Istanbul Üniversitesi - Cerrahpasa Rektörlügü
    34320 Avcilar/Istanbul (TR)

(72) Inventors:
  • GÖKMEN, Zeliha
    34320 Avcilar/Istanbul (TR)
  • ULUKAYA, Engin
    Zeytinburnu/Istanbul (TR)
  • AKAR, Remzi Okan
    Zeytinburnu/Istanbul (TR)

(74) Representative: Yalçiner Patent and Consulting Ltd. 
Tunus Caddesi 85/3-4 Kavaklidere
06680 Ankara
06680 Ankara (TR)

   


(54) AN ANTIMETASTATIC AGENT EFFECTIVE ON PROSTATE CANCER CELLS AND SUITABLE FOR USE IN THE TREATMENT OF THESE DISEASES